AlphaCore Capital LLC Increases Stock Position in AstraZeneca PLC AZN
Published on March 2, 2026
AlphaCore Capital LLC recently announced that it has increased its stock position in AstraZeneca PLC (AZN). This move comes after Harvest Portfolios Group Inc. sold a significant number of shares of the pharmaceutical company. US Bancorp DE also bought shares of AZN, showing confidence in the company's future. Additionally, TD Asset Management Inc acquired shares of AstraZeneca PLC, further highlighting the positive outlook for the company. With these recent developments, it seems that investors are optimistic about the growth potential of AZN in the healthcare sector.
Investor opinions & comments
To leave a comment, you need to Login or Register.
CashChris
March 5, 2026 at 05:32
No estoy seguro de si AstraZeneca PLC es una buena inversión en este momento. Aunque hay compradores y vendedores, todavía tengo dudas sobre su desempeño futuro
SavannahGordon
March 4, 2026 at 15:57
It's great to see investors showing confidence in AstraZeneca PLC. With recent acquisitions and increased stock positions, it seems like the company is positioned for success in the healthcare sector
InvestorIan
March 4, 2026 at 09:47
I'm excited to see AlphaCore Capital LLC increasing their stock position in AstraZeneca PLC. It's a strong move that shows confidence in the company's future growth
PennyPaul
March 3, 2026 at 08:27
Me parece interesante que AlphaCore Capital LLC haya aumentado su posición en AstraZeneca PLC. Parece que confían en el potencial de crecimiento de la empresa